Cost-Benefit Model Comparing Two Alternative Immunisation Programmes Against Serogroup C Meningococcal Disease

This publication has 15 references indexed in Scilit:

• Meningococcal Disease
  New England Journal of Medicine, 2001
• Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis
  Vaccine, 2001
• Meningococcal Vaccines
  Infectious Disease Clinics of North America, 2001
• Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.
  JAMA, 2001
• Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
  The Lancet, 2001
• THE SOCIETAL COSTS OF SEVERE TO PROFOUND HEARING LOSS IN THE UNITED STATES
  International Journal of Technology Assessment in Health Care, 2000
• Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt
  Pathogens and Global Health, 1999
• Induction of Immunologic Memory by Conjugated vs Plain Meningococcal C Polysaccharide Vaccine in Toddlers
  JAMA, 1998
• Pathogenesis and pathophysiology of bacterial meningitis
  Clinical Microbiology Reviews, 1993
• Rehabilitation of below-knee amputees: factors influencing outcome and costs in three programmes
  International Disability Studies, 1989